Autolus Therapeutics (AUTL) Return on Equity [ROE] (2018 - 2026)
Autolus Therapeutics (AUTL) posted Return on Equity [ROE] of -202.80% for Q2 2026, down 139.31 percentage points from -63.49% a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Autolus Therapeutics' Return on Equity [ROE] came in at -94.99%, down 13.08 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -33.87 percentage points (FY2020 to FY2025).
- In prior years, Autolus Therapeutics' Return on Equity [ROE] was -81.91% in FY2024 (+19.70 pp), -101.61% in FY2023 (-52.96 pp), -48.65% in FY2022 (+5.67 pp) and -54.32% in FY2021 (+6.80 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2018.
- On a year-over-year basis, Return on Equity [ROE] increased in three of the last seven quarters, with an average year-over-year change of -19.95 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2024, with a gain of 93.93 percentage points; the weakest was Q2 2026, with a drop of 139.31 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Autolus Therapeutics | 468.91 Mn | -511.27 Mn | 23.31 Mn | -502.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -502.44% |
| Jun 30, 2026 | -312.66% |
| Mar 31, 2026 | -193.40% |
| Dec 31, 2025 | -118.90% |
| Sep 30, 2025 | -128.71% |
| Jun 30, 2025 | -101.44% |
| Mar 31, 2025 | -98.26% |
| Dec 31, 2024 | -85.33% |
| Sep 30, 2024 | -72.34% |
| Jun 30, 2024 | -64.88% |
| Mar 31, 2024 | -98.93% |
| Dec 31, 2023 | -222.32% |
| Sep 30, 2023 | -70.46% |
| Jun 30, 2023 | -60.26% |
| Mar 31, 2023 | -59.70% |
| Dec 31, 2022 | -77.93% |
| Sep 30, 2022 | -107.33% |
| Jun 30, 2022 | -76.28% |
| Mar 31, 2022 | -53.84% |
| Dec 31, 2021 | -51.90% |
API Access
Autolus Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();